Related Experiment Videos
p21WAF1/CIP1 interacts with protein kinase CK2
C Götz1, P Wagner, O G Issinger
1Institute of Medical Biochemistry, University of the Saarland, Homburg, Germany.
Oncogene
|July 18, 1996
Summary
The p21 protein binds to protein kinase CK2, inhibiting its activity and affecting cell cycle regulation. This discovery reveals a new interaction impacting DNA replication and cell growth.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Enzyme Kinetics
Background:
- p21WAF1/CIP1 is a cell cycle inhibitor that interacts with cyclin-dependent kinases and PCNA.
- Protein kinase CK2 (CK2) is a multi-subunit enzyme involved in various cellular processes.
Purpose of the Study:
- To investigate the interaction between p21WAF1/CIP1 and protein kinase CK2.
- To determine the functional consequences of this interaction on CK2 activity.
Main Methods:
- Co-immunoprecipitation assays to detect protein binding.
- In vitro kinase assays to measure CK2 activity.
Main Results:
- p21WAF1/CIP1 specifically binds to the regulatory beta-subunit of CK2, not the catalytic alpha-subunit.
- Binding of p21WAF1/CIP1 downregulates CK2 activity towards its beta-subunit, casein, and the C-terminus of p53.
Conclusions:
- p21WAF1/CIP1 is identified as a novel binding partner for the CK2 beta-subunit.
- This interaction modulates the holoenzyme activity of CK2, suggesting a new regulatory mechanism in cellular processes.